AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications

AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications

Abstract Background Data on antimicrobial resistance mechanisms are scanty for Cedecea spp., with very variable antibiotic resistance patterns documented. Here we report the first in vivo resistance evolution of a C. davisae clinical isolate in a patient with a complex hand trauma and provide insigh...

Full description

Bibliographic Details
Main Authors: Julia Notter, Salome N. Seiffert, Maria Zimmermann-Kogadeeva, Anja Bösch, Robert Wenger, Carol Strahm, Manuel Frischknecht, David M. Livermore, Baharak Babouee Flury
Format: Article
Language:English
Published: BMC 2022-01-01
Series:BMC Infectious Diseases
Subjects:
Cedecea davisae
AmpC
Hyperproducing
Cefepime
Resistance evolution
Case report
Online Access:https://doi.org/10.1186/s12879-021-07000-y

Internet

https://doi.org/10.1186/s12879-021-07000-y

Similar Items